Avalo Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 05/15/2026 | 2.88 M | $42.99 M | 1,207.07% | 21.48% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2026 | 2.16 M | $32.29 M | 100.00% | 16.13% |
| CALIGAN PARTNERS LP | 05/15/2026 | 1.64 M | $24.41 M | 85.48% | 12.20% |
| BVF INC/IL | 05/15/2026 | 1.63 M | $24.38 M | 20.48% | 12.18% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2026 | 1.41 M | $21.05 M | 100.00% | 10.52% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 1.34 M | $20.02 M | 27.57% | 10.00% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.24 M | $18.44 M | 0.00% | 9.21% |
| UBS GROUP AG | 05/05/2026 | 1.14 M | $17.05 M | 139.00% | 8.52% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 1.00 M | $14.93 M | 100.00% | 7.46% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 916.14 K | $13.68 M | 46.00% | 6.83% |
| FARALLON CAPITAL MANAGEMENT LLC | 05/15/2026 | 916.00 K | $13.68 M | 100.00% | 6.83% |
| RTW INVESTMENTS, LP | 05/15/2026 | 856.96 K | $12.79 M | 100.00% | 6.39% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 854.00 K | $12.75 M | 55.27% | 6.37% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 835.48 K | $12.47 M | 26.59% | 6.23% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/15/2026 | 738.38 K | $11.02 M | 52.87% | 5.51% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 731.59 K | $10.92 M | 66.53% | 5.46% |
| 05/15/2026 | 719.69 K | $10.75 M | 100.00% | 5.37% | |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 662.97 K | $9.90 M | 0.00% | 4.95% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 643.00 K | $9.60 M | 3.48% | 4.80% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 631.70 K | $9.43 M | 531.70% | 4.71% |
| COMMODORE CAPITAL LP | 05/15/2026 | 483.00 K | $7.21 M | 0.00% | 3.60% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 475.17 K | $7.09 M | -59.98% | 3.54% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 474.20 K | $7.08 M | 681.22% | 3.54% |
| JENNISON ASSOCIATES LLC | 05/06/2026 | 470.78 K | $7.03 M | -1.02% | 3.51% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 455.00 K | $6.79 M | 764.35% | 3.39% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 441.98 K | $6.60 M | 0.00% | 3.30% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 422.78 K | $6.31 M | 113.80% | 3.15% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 401.50 K | $5.99 M | 591.05% | 3.00% |
| KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2026 | 387.98 K | $5.79 M | 100.00% | 2.89% |
| DV TRADING LLC | 05/15/2026 | 360.06 K | $5.38 M | 100.00% | 2.69% |
| BLACKROCK, INC. | 05/13/2026 | 327.08 K | $4.88 M | 12.95% | 2.44% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 324.26 K | $4.84 M | 60.42% | 2.42% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 300.00 K | $4.48 M | 100.00% | 2.24% |
| BOXER CAPITAL MANAGEMENT, LLC | 05/15/2026 | 300.00 K | $4.48 M | 9.09% | 2.24% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 05/14/2026 | 295.93 K | $4.42 M | 100.00% | 2.21% |
| 06/04/2026 | 213.82 K | $3.19 M | 237.56% | 1.60% | |
| JPMORGAN CHASE & CO | 05/13/2026 | 194.39 K | $2.71 M | 337.51% | 1.45% |
| CITADEL ADVISORS LLC | 05/15/2026 | 193.74 K | $2.89 M | -53.82% | 1.45% |
| NAN FUNG TRINITY (HK) LTD | 05/05/2026 | 189.00 K | $2.82 M | 0.00% | 1.41% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 185.12 K | $2.76 M | -29.78% | 1.38% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 174.51 K | $2.61 M | 170.71% | 1.30% |
| JANE STREET GROUP, LLC | 05/12/2026 | 173.32 K | $2.59 M | -3.09% | 1.29% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 172.15 K | $2.57 M | -21.02% | 1.28% |
| ABRDN PLC | 04/29/2026 | 171.68 K | $2.56 M | 79.91% | 1.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 169.89 K | $2.54 M | 2.25% | 1.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 163.00 K | $2.43 M | 570.78% | 1.22% |
| MORGAN STANLEY | 05/15/2026 | 161.39 K | $2.41 M | -39.08% | 1.20% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 161.09 K | $2.41 M | 860.51% | 1.20% |
| EXOME ASSET MANAGEMENT LLC | 05/15/2026 | 159.34 K | $2.38 M | 100.00% | 1.19% |
| MOODY ALDRICH PARTNERS LLC | 04/20/2026 | 159.32 K | $2.38 M | 19.58% | 1.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avalo Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 120 institutional investors and hedge funds held shares of Avalo Therapeutics Inc. The most heavily invested institutionals were:
FMR LLC: 2.88 M
T. Rowe Price Investment Management, Inc.: 2.16 M
Caligan Partners LP: 1.64 M
BVF INC/IL: 1.63 M
Avoro Capital Advisors LLC: 1.41 M
Affinity Asset Advisors, LLC: 1.34 M
232.04% of Avalo Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 31.08 M shares in the last 24 months. This purchase volume represents approximately $537.96 M in transactions.